scispace - formally typeset
Search or ask a question
Institution

Anthony Nolan

NonprofitLondon, England, United Kingdom
About: Anthony Nolan is a nonprofit organization based out in London, England, United Kingdom. It is known for research contribution in the topics: Transplantation & Human leukocyte antigen. The organization has 230 authors who have published 272 publications receiving 13641 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: It was found that 80% possessed the HLA antigen DR3, which confers increased immune responsiveness and a predisposition to ‘auto‐immune disease’, which suggests that the development of herpes gestationis may depend on exposure to an antigen derived from the father.
Abstract: In a study of twenty-five patients with herpes gestationis we found that 80% possessed the HLA antigen DR3, which confers increased immune responsiveness and a predisposition to 'auto-immune disease'. In five patients the development of herpes gestationis coincided with a change in sexual partner, suggesting that the development of herpes gestationis may depend on exposure to an antigen derived from the father. This might share determinants with a component of the basement membrane zone of skin. Although anti-basement membrane zone antibodies are present in HG it is not clear whether they play a pathogenic role. The infrequency of neonatal involvement and the lack of correlation between immunofluorescence findings and clinical activity in our patients suggested that the antibodies might be a result of tissue damage rather than its cause. Two patients in our study were exceptional in that episodes of herpes gestationis were followed by normal pregnancies. In these patients the relationship of their DR antigens to those of the fetus may have been important in determining whether or not the pregnancy would be affected by herpes gestationis.

92 citations

Patent
08 Nov 2004
TL;DR: In this article, a portable proximity alert detector is provided for a user to determine when at least one companion comes within a predetermined range of the user, and an indicator is provided to alert the user when one companion identifying code received by the receiving portion matches one of the companion identifying codes stored in the second memory segment.
Abstract: A portable proximity alert detector is provided for a user to determine when at least one companion comes within a predetermined range of the user. The device includes a receiving portion for wirelessly receiving a first signal encoded with a code identifying a companion and a transmitting portion for wirelessly transmitting a second signal encoded with a user identifying code. The device also includes a processor, a modulator operationally coupling the processor to the transmitting portion for modulating the user identifying code, and a demodulator operationally coupling the processor to the receiving portion for demodulating the companion identifying code. A first memory segment is operationally coupled to the processor for storing companion identifying codes received by the receiving portion. A second memory segment is operationally coupled to the processor for storing companion identifying codes of companions whom the user desires to contact. A third memory segment operationally coupled to the processor for storing the user identifying code. A user interface is operationally coupled to the processor through which the companion identifying codes of the companions whom the user desires to contact are programmed into the second memory segment. An indicator is provided for alerting the user when at least one companion identifying codes received by the receiving portion matches one of the companion identifying codes stored in the second memory segment.

85 citations

Journal ArticleDOI
TL;DR: UK consensus guidelines on the selection of umbilical cord blood units, the hierarchy of donor selection and the preferred conditioning regimens for umbilicals cord blood transplantation are reported, with a summary of rationale supporting these recommendations.
Abstract: Allogeneic haemopoietic stem cell transplantation offers a potentially curative treatment option for a wide range of life-threatening malignant and non-malignant disorders of the bone marrow and immune system in patients of all ages. With rapidly emerging advances in the use of alternative donors, such as mismatched unrelated, cord blood and haploidentical donors, it is now possible to find a potential donor for almost all patients in whom an allograft is indicated. Therefore, for any specific patient, the transplant physician may be faced with a myriad of potential choices, including decisions concerning which donor to prioritize where there is more than one, the optimal selection of specific umbilical cord blood units and which conditioning and graft-versus-host disease prophylactic schedule to use. Donor choice may be further complicated by other important factors, such as urgency of transplant, the presence of alloantibodies, the disease status (homozygosity or heterozygosity) of sibling donors affected by inherited disorders and the cytomegalovirus serostatus of patient and donor. We report UK consensus guidelines on the selection of umbilical cord blood units, the hierarchy of donor selection and the preferred conditioning regimens for umbilical cord blood transplantation, with a summary of rationale supporting these recommendations.

80 citations

Journal ArticleDOI
TL;DR: To ameliorate this situation, it is essential to improve quality at each of the critical manufacturing steps wherein potency can be threatened, thereby creating homogeneous inventories of units with excellent quality and quantity.
Abstract: Growing inventories of cord blood units have facilitated access to umbilical cord cell transplantation for many patients lacking conventional stem cell donors. They are in principle 'off-the-shelf', 'fit-for-use', as well as safe and effective therapy products. Cellular enumeration is used as a surrogate of graft potency, and users rely on the rigorous assessment carried out in banks to avoid poor engraftment after thawing (loss of cells or poor function), when the patient's situation is critical. However, in practice, when units are selected, initially on the basis of HLA matching and cell dose assessment, their absolute quality remains uncertain. Unfortunately, quality-related issues (particularly related to viability) are not uncommon in cord blood transplantation. The reasons for potency failures are diverse, but a lack of thorough validation during critical steps of the process and of appropriate use of quality-control tools for timely detection of problematic units are significant contributors. Moreover, incongruence between different sets of standards and regulations, and lack of common quality systems between banks result in a highly heterogeneous international inventory. Therefore, this complicates the matter for the end user of the product. To ameliorate this situation, it is essential to improve quality at each of the critical manufacturing steps wherein potency can be threatened, thereby creating homogeneous inventories of units with excellent quality and quantity.

80 citations

Journal ArticleDOI
24 Dec 2015-Blood
TL;DR: Comparing the ability of HLA-mismatched CB and adult peripheral blood T cells to eliminate Epstein-Barr virus-driven human B-cell lymphoma in a xenogeneic NOD/SCID/IL2rg(null) mouse model suggests reconstituting T cells after unrelated T-replete CBT may provide superior Tc1-Th1 antitumor effects against high-risk hematologic malignancies.

79 citations


Authors

Showing all 236 results

NameH-indexPapersCitations
Ghulam J. Mufti8868730934
Nigel H. Russell7650221810
Steven G.E. Marsh6548720763
Frits van Rhee6132314983
Charles Craddock6030213660
James Robinson4817211429
John Barrett441147428
Bronwen E. Shaw422866191
Richard Szydlo411664775
Nancy F. Hensel34874754
Alejandro Madrigal291013529
Lawrence S. Lamb28882311
Susana Gómez27691891
Ann-Margaret Little26632443
J. Alejandro Madrigal261052577
Network Information
Related Institutions (5)
City of Hope National Medical Center
16.4K papers, 755.4K citations

83% related

St. Jude Children's Research Hospital
19.2K papers, 1.2M citations

81% related

Fred Hutchinson Cancer Research Center
30.9K papers, 2.2M citations

81% related

Walter and Eliza Hall Institute of Medical Research
10.6K papers, 873.5K citations

81% related

Cincinnati Children's Hospital Medical Center
29.7K papers, 1.1M citations

80% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20234
20224
202113
202011
20197
201813